Healthcare Pharmaceuticals Ltd. (HPL) began its journey in 1988 in collaboration with Roche, a renowned Swiss pharmaceutical company. Initially, it focused on importing and distributing Roche products before deciding in 1996 to establish its own manufacturing facility. Commercial production started in 2002, marking an important step in its growth. Today, HPL is one of Bangladesh’s leading pharmaceutical companies, producing more than 630 products across a wide range of therapeutic categories, including cardiovascular diseases, diabetes, oncology, respiratory conditions, and eye care. HPL combines modern manufacturing technology with strict quality standards to develop safe and effective medicines. Its facilities produce tablets, capsules, injections, eye drops, inhalers, and other dosage forms. The company exports pharmaceutical products to more than 32 countries across Asia, Africa, Europe, and other regions. Through continuous innovation, international partnerships, and a strong focus on product quality, HPL aims to improve patient health in Bangladesh and beyond.